Silva Junior Geraldo Bezerra da, Daher Elizabeth De Francesco, Pires Neto Roberto da Justa, Pereira Eanes Delgado Barros, Meneses Gdayllon Cavalcante, Araújo Sônia Maria Holanda Almeida, Barros Elvino José Guardão
School of Medicine, Master in Collective Health, Health Sciences Center, University of Fortaleza, Fortaleza, Ceará, Brazil.
Post-Graduation Program in Medical Sciences, Department of Internal Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):15-20. doi: 10.1590/S0036-46652015000100002.
Leprosy is a chronic disease caused by Mycobacterium leprae, highly incapacitating, and with systemic involvement in some cases. Renal involvement has been reported in all forms of the disease, and it is more frequent in multibacillary forms. The clinical presentation is variable and is determined by the host immunologic system reaction to the bacilli. During the course of the disease there are the so called reactional states, in which the immune system reacts against the bacilli, exacerbating the clinical manifestations. Different renal lesions have been described in leprosy, including acute and chronic glomerulonephritis, interstitial nephritis, secondary amyloidosis and pyelonephritis. The exact mechanism that leads to glomerulonephritis in leprosy is not completely understood. Leprosy treatment includes rifampicin, dapsone and clofazimine. Prednisone and non-steroidal anti-inflammatory drugs may be used to control acute immunological episodes.
麻风病是一种由麻风分枝杆菌引起的慢性疾病,具有高度致残性,在某些情况下会累及全身。在麻风病的所有类型中均有肾脏受累的报道,且在多菌型中更为常见。临床表现多样,取决于宿主免疫系统对杆菌的反应。在疾病过程中会出现所谓的反应状态,即免疫系统对杆菌产生反应,加剧临床表现。麻风病中已描述了不同的肾脏病变,包括急性和慢性肾小球肾炎、间质性肾炎、继发性淀粉样变性和肾盂肾炎。导致麻风病肾小球肾炎的确切机制尚未完全明确。麻风病的治疗包括利福平、氨苯砜和氯法齐明。泼尼松和非甾体类抗炎药可用于控制急性免疫反应发作。